| Anoop P Sangha, MD | |
|
8949 S Kingston Ave, Tulsa, OK 74137-3016 | |
| (918) 813-7560 | |
| Not Available |
| Full Name | Anoop P Sangha |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 8949 S Kingston Ave, Tulsa, Oklahoma |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063439974 | NPI | - | NPPES |
| 00A959280 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | A95928 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Anoop P Sangha, MD 8949 S Kingston Ave, Tulsa, OK 74137-3016 Ph: (918) 813-7560 | Anoop P Sangha, MD 8949 S Kingston Ave, Tulsa, OK 74137-3016 Ph: (918) 813-7560 |
News Archive
The U.S. Food and Drugs Administration (FDA) has restricted the use of the controversial diabetes drug Avandia (rosiglitazone) due to its propensity to increase cardiovascular disease risk.
Affymetrix, Inc. today announced commercialization of the next-generation human transcriptome array demonstrated by Stanford University researchers to be superior to mRNA sequencing (RNA-Seq) in gene expression profiling studies.
A pair of new thin, transparent devices, constructed with soft lithography, should boost research in which nematodes are studied to explore brain-behavior connections and to screen new pharmaceuticals for potential treatment of parasitic infections in humans, report 10 scientists at three institutions.
Genetic testing may rise to a new level with the findings of Indiana University School of Medicine researchers whose "prototype" for laboratory testing for bipolar disorder appears today in the online edition of the American Journal of Medical Genetics Part B: Neuropsychiatric Genetics.
Rigel Pharmaceuticals, Inc. today announced that it has commenced Phase 2 clinical studies with two of the company's most advanced proprietary therapeutic product candidates. R343 is an inhaled SYK inhibitor that is being evaluated as a potential treatment for allergic asthma.
› Verified 6 days ago
Hoi Y Chan, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 6161 S Yale Ave, Tulsa, OK 74136 Phone: 918-494-6161 | |
Dr. Cory Brit Kebert, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1717 S Utica Ave Ste A, Tulsa, OK 74104 Phone: 981-748-7557 Fax: 918-748-7514 | |
Mr. Michael Daniel Figueiredo, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4502 E 41st St, Tulsa, OK 74135 Phone: 918-619-4400 | |
Dr. Julie Christa Dodson, Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1120 S Utica Ave, Tulsa, OK 74104 Phone: 918-579-1000 | |
Steven L. Nussbaum, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 9716 Riverside Parkway, Suite 100, Tulsa, OK 74137 Phone: 918-299-4333 Fax: 918-299-4330 | |
Dr. Stephen Hodges Thomas, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 4502 E 41st St, Tulsa, OK 74135 Phone: 918-660-3831 Fax: 918-660-3821 | |
Eric Brady Woolley, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1120 S Utica Ave, Tulsa, OK 74104 Phone: 918-949-1884 |